Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of trilensin component a in sanleng in the preparation of anti-blood stasis medicine

A technology of blood stasis syndrome and trilens, which is applied in the field of medicine, can solve the problem that the active ingredients of sanlens are not clear enough

Active Publication Date: 2021-03-16
GUANGDONG PHARMA UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved by the present invention is to overcome the defects and deficiencies of the existing three-lens active ingredients that are not clear enough, and prove for the first time that three-lens A and three-lens B have the medicinal effect of anti-blood stasis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of trilensin component a in sanleng in the preparation of anti-blood stasis medicine
  • Application of trilensin component a in sanleng in the preparation of anti-blood stasis medicine
  • Application of trilensin component a in sanleng in the preparation of anti-blood stasis medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1 compound blood circulation promoting function experiment

[0027] 1. Experimental materials

[0028] (1) Drugs: Trilens A, Trisensin B and Trisensin C were self-made in the experiment, with a purity of ≥99%.

[0029] (2) Animal: KM mouse, ♀, body weight 25±5g, provided by Guangdong Experimental Animal Center, license number: SCK (Guangdong) 2013-0002.

[0030] (3) Reagents

[0031] Epinephrine Hydrochloride Injection (Grand Medicine (China) Co., Ltd., batch number: 20170214); Bayer Aspirin Enteric-Coated Tablets (Bayer Healthcare Co., Ltd., batch number: BJ32400); Carboxymethylcellulose Sodium (CMC-Na, Sinopharm Chemicals Reagent Co., Ltd., batch number: F20110915, analytically pure); sodium chloride (Tianjin Zhiyuan Chemical Reagent Co., Ltd., batch number: 20160312, analytically pure); mouse thromboxane B2 (TXB2), endothelin 1 (ET-1), Plasminogen activator inhibitor 1 (PAI-1), fibrinogen (FIB) enzyme-linked immunoassay kit (Tianjin Anoricang Biotechnology...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an anti-blood stasis syndrome application of a scirpusin A component in Rhizoma Sparganii. It is firstly proved that the scirpusin A has a significant anti-blood stasis drug effect, and can be used to prepare drugs for treating blood stasis syndromes. Pharmacological experiments prove that the scirpusin A can significantly reduce the Thromboxane B2 (TXB2) level, the fibrinogen (FIB) level, the tissue plasminogen inhibitor-1 (Active Plasminogen Activator Inhibitor-1, PAI-1) level and the endothelin (ETo-1) level in serum of a blood stasis model mouse, can improve the thymus index (TI), the spleen index (SI) and the hepatic index (HI) index of the mouse, and has high clinical application values and a broad development prospect in the treatment of blood stasis syndromes.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of a trigonin component (trigenin A) in anti-blood stasis syndrome. Background technique [0002] Sanleng is the dry tuber of Sparganium stoloni erum Buch.-Ham., a plant of the family Black Trigonaceae, which has been recorded in previous "Chinese Pharmacopoeia". Qi, eliminating stagnation and relieving pain. Sanleng can be used alone in raw products and vinegar products, and can also be combined with curcuma and astragalus to enhance the curative effect. It is mainly used in the treatment of endometriosis, uterine fibroids and other gynecological diseases, as well as liver diseases and cardiovascular and cerebrovascular diseases. and other diseases. [0003] The chemical composition of Sanleng is complex, containing flavonoids, volatile oils, phenylpropanoids, organic acids, alkaloids, anthraquinones, steroids and polypeptides. Modern pharmacological research...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4965A61P7/02
CPCA61K31/4965A61P7/02
Inventor 梁生旺冀苏龙王淑美许晓丽
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com